Dulcolax and Injection site swelling - a phase IV clinical study of FDA data

Summary:

Injection site swelling is reported as a side effect among people who take Dulcolax (bisacodyl), especially for people who are female, 60+ old, also take Vitamin B12, and have Muscle spasms.

The phase IV clinical study analyzes which people have Injection site swelling when taking Dulcolax. It is created by eHealthMe based on reports of 12,769 people who have side effects when taking Dulcolax from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,057 drugs and 1,115 conditions by eHealthMe. Check the latest studies of Injection site swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

12,769 people reported to have side effects when taking Dulcolax.
Among them, 13 people (0.1%) have Injection site swelling.

Could Dulcolax cause Injection site swelling?

Among these 13 people:

What is the gender of people who have Injection site swelling when taking Dulcolax? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Injection site swelling when taking Dulcolax? *

What are other drugs people take besides Dulcolax? *

What are other side effects people have besides Injection site swelling? *

Injection Site Pain: 6 people, 46.15%
Injection Site Erythema (redness at injection site): 5 people, 38.46%
Chest Pain: 3 people, 23.08%
Fatigue (feeling of tiredness): 3 people, 23.08%
Pain In Extremity: 3 people, 23.08%
Insomnia (sleeplessness): 2 people, 15.38%
Injection Site Warmth: 2 people, 15.38%
Injection Site Urticaria (rash of round, red welts on the skin at injection site): 2 people, 15.38%
Injection Site Rash: 2 people, 15.38%
Injection Site Pruritus (severe itching at injection site): 2 people, 15.38%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 23.08%
Muscle Spasms (muscle contraction): 3 people, 23.08%
Migraine (headache): 2 people, 15.38%
Gait Disturbance: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Asthma: 1 person, 7.69%
Gastric Ph Decreased: 1 person, 7.69%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and have Injection site swelling?

- Check whether Injection site swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dulcolax:

Dulcolax (12,897 reports)

Browse all side effects of Dulcolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site swelling:

Injection site swelling (1,058 drugs)

Browse all the conditions that are associated with Injection site swelling:

Injection site swelling (1,115 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl (the active ingredients of Dulcolax) and Dulcolax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.